AIM
Price
$0.12
Change
-$0.02 (-14.29%)
Updated
Mar 3, 04:41 PM (EDT)
Capitalization
9.28M
34 days until earnings call
SLN
Price
$4.32
Change
-$0.18 (-4.00%)
Updated
Mar 3, 04:59 PM (EDT)
Capitalization
208.22M
Ad is loading...

AIM vs SLN

Header iconAIM vs SLN Comparison
Open Charts AIM vs SLNBanner chart's image
AIM ImmunoTech
Price$0.12
Change-$0.02 (-14.29%)
Volume$5K
Capitalization9.28M
Silence Therapeutics
Price$4.32
Change-$0.18 (-4.00%)
Volume$1.63K
Capitalization208.22M
AIM vs SLN Comparison Chart
Loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIM vs. SLN commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Hold and SLN is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (AIM: $0.14 vs. SLN: $4.34)
Brand notoriety: AIM and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 24% vs. SLN: 65%
Market capitalization -- AIM: $9.28M vs. SLN: $208.22M
AIM [@Biotechnology] is valued at $9.28M. SLN’s [@Biotechnology] market capitalization is $208.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • AIM’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both AIM and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 6 bullish TA indicator(s).

  • AIM’s TA Score: 4 bullish, 5 bearish.
  • SLN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SLN is a better buy in the short-term than AIM.

Price Growth

AIM (@Biotechnology) experienced а -2.39% price change this week, while SLN (@Biotechnology) price change was -10.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.35%. For the same industry, the average monthly price growth was -9.54%, and the average quarterly price growth was -4.71%.

Reported Earning Dates

AIM is expected to report earnings on May 15, 2025.

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($208M) has a higher market cap than AIM($9.28M). AIM YTD gains are higher at: -31.818 vs. SLN (-36.919). AIM has higher annual earnings (EBITDA): -26.19M vs. SLN (-56.89M). SLN has more cash in the bank: 129M vs. AIM (7.2M). SLN has less debt than AIM: SLN (139K) vs AIM (3.4M). SLN has higher revenues than AIM: SLN (16.2M) vs AIM (190K).
AIMSLNAIM / SLN
Capitalization9.28M208M4%
EBITDA-26.19M-56.89M46%
Gain YTD-31.818-36.91986%
P/E RatioN/AN/A-
Revenue190K16.2M1%
Total Cash7.2M129M6%
Total Debt3.4M139K2,447%
FUNDAMENTALS RATINGS
AIM: Fundamental Ratings
AIM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AIMSLN
RSI
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
90%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Ad is loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
J128.111.57
+1.24%
Jacobs Solutions
SCPH3.280.04
+1.23%
scPharmaceuticals
BH245.122.79
+1.15%
Biglari Holdings
CELZ4.97-0.08
-1.58%
Creative Medical Technology Holdings
QS4.69-0.11
-2.29%
QuantumScape Corp